BTIG Reiterates Buy on Verastem, Maintains $24 Price Target

BTIG analyst Jeet Mukherjee has reiterated a Buy rating on Verastem (NASDAQ: VSTM) and maintained a price target of $24 for the stock. This endorsement suggests confidence in the company's future performance.